C

Cencora

Distributes medicines and supports patient care

Pharmacy Concierge Technician

Full-TimeUpdated on 10/24/2026
$26
Mid
Associate's
Philadelphia, PA, USA
In PersonOn-site at Apple Pharmacy at St. Christopher's, 160 E. Erie Ave, Philadelphia, PA 19134; Monday–Friday with rotating weekends.
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • Requires at least three years of experience in a community-based retail or hospital outpatient pharmacy, or equivalent training and experience.
  • Demonstrated proficiency and process knowledge of outpatient prescription program payer and pharmacy benefit manager billing, issue resolution, and payment processes, including prior authorization and claim exception facilitation.
  • Understanding and process knowledge of medication billing systems in an ambulatory pharmacy setting.
  • Demonstrated computer literacy, including pharmacy operating system experience and Word and Excel capabilities.
  • Prior point-of-sale and cash register experience is required.
  • By May 2026, pharmacy technicians must obtain either a Pharmacy Technician Trainee license or a Pharmacy Technician license issued by the state of Pennsylvania. Employees holding a Trainee license must upgrade to a Technician license before the Trainee license expires.
  • Ability to communicate effectively both orally and in writing.
  • Ability to work quickly and accurately under time and volume constraints.
  • Ability to resolve customer issues quickly and creatively to improve customer satisfaction.
  • Ability to prioritize, facilitate, and problem-solve multiple time-sensitive tasks to completion.
  • Strong organizational, record-keeping, and time management skills.
  • Familiarity with pharmaceutical products, services, and drug interactions.
  • Strong organizational skills and attention to detail.
  • Good analytical skills.
Responsibilities
  • Collaborate with internal team members to gather appropriate paperwork, prescription billing information, and prescriptions.
  • Answer inbound telephone calls and triage calls to appropriate staff.
  • Create patient profiles in the pharmacy information system.
  • Enter prescription plan information in patient profiles to process and adjudicate patients’ prescriptions.
  • Support Concierge Service activities from prescription intake through bedside delivery at patient discharge.
  • Comply with established regulatory and organizational policies and procedures.
  • Participate in program marketing and promotional campaigns.
  • Assist in establishing policies and procedures for the Concierge Services Program, including the indigent drug program, Patient Assistance Programs, and pharmacy exception processes.
  • Serve as the primary ambulatory pharmacy resource to facilitate access and resolve discharge medication issues, including formulary and coverage issues, copay issues, Patient Assistance Program eligibility, and other indigent programs.
  • Prepare inventory reports for pharmacist review and purchasing.
  • Submit, receive, and place inventory in stock using knowledge of order placement, receiving, and merchandising.
  • Follow up with patients and families about pharmaceutical needs or additional eligibility information to ensure ongoing medication access.
  • Work with appropriate departments and internal patient care team members regarding patients with limited financial resources for prescription medication, and collaborate as required to create medication access in support of discharge preparations.
  • Collaborate with internal team members, insurance companies, drug manufacturers, and prescription benefit administrators to coordinate drug coverage or resolve denials.
  • Educate pharmacy and other patient discharge-related departments about current policies and processes for the Patient Assistance Program and pharmacy exception process.
  • Participate in achieving clinical and business goals and metrics for the Ambulatory Pharmacy Concierge Program.
  • Assemble data and prepare concierge program reports.
  • Perform other duties as assigned.
Desired Qualifications
  • Additional experience in a hospital setting or lead Technician experience is a plus.
  • An Associate’s Degree program is preferred.
  • Certified Pharmacy Technician certification is preferred.
  • Pharmacy point-of-sale or cash register experience is desired.
  • Direct experience and knowledge of Patient Assistance Programs and/or indigent drug programs is highly desired.

About the company

Cencora buys and distributes medicines for pharmacies, hospitals and physician practices, while helping drug manufacturers bring treatments to patients. Its businesses combine wholesale supply networks with specialty distribution for complex therapies and services that support prescribing and patient access. Customers order medicines through its distribution systems, and its teams manage sourcing, storage and delivery alongside pharmacy operations and manufacturer support. It earns revenue from pharmaceutical sales and fees for logistics and healthcare services. The parent company was formed in 2001 through the merger that created AmerisourceBergen, adopted the Cencora name in 2023, and is headquartered in Conshohocken, Pennsylvania.

Company Size

10,001+

Company Stage

IPO

Headquarters

Conshohocken, Pennsylvania

Founded

2001

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharmacy contracts deepen customer ties: Cencora negotiates insurer agreements and handles administrative work through its managed-care networks.
  • Eligible US staff gain retirement support: Cencora counts student-loan payments toward its employer match, up to 4% of pay.
  • Drug demand expands sales: Cencora reported 5.1% quarterly revenue growth in August 2026, led by higher US volumes.

What critics are saying

  • Customer dependence concentrates risk: Walgreens and Boots supplied 25% of Cencora's fiscal 2025 revenue, reported in November 2025.
  • Legal liabilities tie up cash: Cencora's November 2025 filing recorded $4.3 billion in opioid settlements, payable over 13 years.
  • Warehouse work is physical: Cencora's day-shift associate listing requires repeated lifting up to 50 pounds and overtime availability.

What makes Cencora unique

  • Independent pharmacies get a shared brand: Cencora's Good Neighbor Pharmacy franchise supports their merchandising and store identity.
  • Specialty shipments use reusable packaging: Cencora's World Courier Cocoon containers combine passive temperature control with live location monitoring.
  • Medicines arrive ready for bedside checks: Cencora's American Health Packaging sells barcoded unit doses that support hospital scanning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Parental Leave
  • Adoption Assistance
  • Infertility Coverage
  • Family Planning Benefits
  • Behavioral Health Solutions
  • Professional Development Budget
  • Training Programs

Company News

Financial News
Oct 21st, 2026
Cencora to buy American Oncology Network in $2.4bn deal

Cencora agrees to buy American Oncology Network for $2.4bn enterprise value, but a stockholder rollover means it may land only 75% of the company.

Yahoo Finance
Oct 16th, 2026
Cencora stock: $332.8B revenue, 14.4% EPS growth and 50.2% ROIC

Cencora, the pharmaceutical distributor formerly known as AmerisourceBergen, has risen 6% to $341.69 per share over the past six months. The S&P 500 gained 9.7% in the same period. The New York Stock Exchange-listed company (NYSE:COR) connects drug manufacturers with healthcare providers and offers logistics, data analytics, and consulting services. It rebranded in 2023. Its revenue reached $332.8 billion over the past 12 months, giving it scale and bargaining power with suppliers. That matters in a low-margin, volume-driven business. Earnings per share grew at a 14.4% compound annual rate over five years, outpacing 10.2% annualised revenue growth. Its five-year average return on invested capital was 50.2%. The shares trade at 17.4 times forward earnings.

Associated Press
Sep 2nd, 2026
Cencora launches cell and gene therapy service to help health systems scale advanced treatment programmes

Cencora has launched Cell and Gene Therapy Enablement through its Accelerate Pharmacy Solutions division to help health systems develop and expand cell and gene therapy programmes. The service provides support across financial planning, operational readiness, and scalable growth to reduce care barriers and improve patient access to advanced therapies. More than 35 cell and gene therapies have received FDA approval, with over 1,700 clinical trials underway globally. However, only 4% of health system pharmacy leaders report being fully prepared to integrate these treatments, highlighting infrastructure gaps. The offering includes market assessments, readiness evaluations, governance design, and workflow planning. Cencora, ranked number 10 on the Fortune 500 with over $300 billion in annual revenue, already provides specialty pharmaceutical services across the therapy lifecycle.

Yahoo Finance
Aug 14th, 2026
Cencora beats Q2 profit estimates as specialty pharma platform drives growth

Cencora reported second-quarter revenue of $84.75 billion, slightly above analyst estimates of $84.43 billion, representing 5.1% year-on-year growth. Adjusted earnings per share came in at $4.48, beating consensus estimates of $4.35 by 3%. Management attributed the performance to strength in specialty pharmaceuticals, particularly through Management Services Organisations like OneOncology and RCA. CEO Robert Mauch highlighted the company's positioning in specialty care, stating, "Our specialty platform supports growth across the healthcare ecosystem." The company raised its full-year adjusted EPS guidance to $17.85 at the midpoint. Operating margin held steady at 1.3%, matching the same quarter last year. During the earnings call, analysts questioned management about biosimilar opportunities, specialty logistics competition, and potential policy risks from proposed ASP rule changes.

Yahoo Finance
Aug 12th, 2026
Cencora raises FY2026 guidance after Q3 EPS jumps 12%, buys back $1B in shares

Cencora reported strong third-quarter results for fiscal year 2026, driven by execution across its business units and investments in its specialty positioning. The pharmaceutical distributor achieved double-digit adjusted operating income growth and 12% earnings per share growth in the quarter. The company conducted $1 billion in opportunistic share repurchases during the period. Based on its performance and confidence in continued execution, Cencora raised its fiscal 2026 EPS guidance. President and CEO Robert Mauch credited the results to the company's team members and their commitment to providing solutions for customers. He highlighted the strength of Cencora's portfolio and its pharmaceutical-centric strategy as the company approaches the end of its fiscal year. The earnings call was held on 5 August 2026, with senior leadership including Mauch and CFO Eva Boratto participating.